Sak Corp insider trades: Idenix Pharmaceuticals (IDIX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sak Corp reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 31, 2014 | IDIX | ↑ Buy | 16,420,241 | $6.50 | $106.7M | Indirect | Feb 4, 2014 (4d) |
| Sep 4, 2009 | FACT | ↓ Sell | 867,532 | $15.43 | $13.4M | I | Sep 8, 2009 (4d) |
| Nov 26, 2008 | RHIE | ↑ Buy | 181,400 | $4.00 | $726K | 1 | Dec 1, 2008 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sak Corp's insider trades
Sak Corp is a 10% owner of Idenix Pharmaceuticals (IDIX). Since Nov 26, 2008, it has reported 2 open-market purchases worth $107.5M and 1 sale worth $13.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.